3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
61
INDUSTRY
11
OTHER_GOV
2
NIH
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
2
Lymphoid
1
Conditions
Lymphoma
159
Precursor Cell Lymphoblastic Leukemia-Lymphoma
130
Leukemia
72
Lymphoma, Large B-Cell, Diffuse
61
Leukemia, Lymphocytic, Chronic, B-Cell
56
Burkitt Lymphoma
56
Hodgkin Disease
55
Lymphoma, Follicular
48
Lymphoma, Non-Hodgkin
43
Lymphoma, Mantle-Cell
35
Lymphoma, Large-Cell, Anaplastic
32
Leukemia, Myeloid, Acute
27
Lymphoma, B-Cell, Marginal Zone
25
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
24
Lymphoma, Large-Cell, Immunoblastic
24
Leukemia, Biphenotypic, Acute
24
Waldenstrom Macroglobulinemia
23
Recurrence
21
Lymphoma, T-Cell, Cutaneous
21
Mycosis Fungoides
18
Dendritic Cell Sarcoma, Interdigitating
18
Sezary Syndrome
16
Immunoblastic Lymphadenopathy
14
Myelodysplastic Syndromes
13
Leukemia, Myelomonocytic, Juvenile
13
Leukemia, Myelomonocytic, Chronic
13
Central Nervous System Neoplasms
13
Myeloproliferative Disorders
12
Multiple Myeloma
12
Blast Crisis
12
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Neoplasm, Residual
×
Lymphoid
×
Clear all
NCT04716075
2025-01-16
ACALLO
Polish Lymphoma Research Group
Phase 2
Completed
29 enrolled